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Craniopharyngiomas are biologically benign lesions (WHO Grade 1) of the sellar and
suprasellar region, associated with a serious morbidity. About 50% of these tumors
become clinically apparent during childhood. Clinical symptoms include headaches, chiasm
syndrome, hydrocephalus, pituitary insufﬁciencies, and obesity. Growth arrest is a typical
symptom in children. The treatment of craniopharyngiomas includes surgery as well as
radiotherapy. The goal of surgery varies according to the tumor location and extension
and may range from complete resection to biopsy. Surgical complications are well known
and cause constant evaluation of surgical strategies. Diencephalic obesity is related to
surgical manipulation of hypothalamic tissue. Therefore, a classiﬁcation system for cranio-
pharyngiomas based on preoperative MRI is suggested by the authors. Recurrences are
frequent in craniopharyngiomas, even after complete or gross-total resection. Radiotherapy
is therefore recommended to patients with incomplete resections. However, the ideal time
for radiotherapy after surgery is under discussion. The treatment of craniopharyngiomas
requires an interdisciplinary and multimodal approach. Each patient should receive an indi-
vidually tailored treatment. Surgically, different approaches as well as different degrees of
resection can be considered, depending on tumor location and tumor extension.
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INTRODUCTION
Although considered benign lesions by biological means, the (sur-
gical) treatment of craniopharyngiomas remains a true challenge
for physicians (Komotar et al., 2009; Crowley et al., 2010). The
problems accompanied by craniopharyngiomas are caused by the
delicate location of these tumors, supposedly arising from rem-
nants of the Rathke’s pouch and connected to neuroendocrine
tissue of the pituitary, the pituitary stalk, or/and hypothalamic
structures. Especially during childhood, when body development
and growth are immediately inﬂuenced by the hypothalamic–
pituitary axis, any disruption of the neuroendocrine function has
severe consequences for the patient. Impaired cognitive and social
abilities are reported independent of endocrine insufﬁciencies
(Ondruch et al., 2011). Any surgical treatment should consider
the rule “primum non nocere”however, surgically induced compli-
cations/loss of functions are well known and lead to a continuous
evaluation of surgical strategies.
Clinical symptoms of childhood craniopharyngiomas include
growth arrest, headaches, chiasmatic syndrome, hydrocephalus,
panhypopituitarism, and obesity, depending on the exact loca-
tion of the tumor and its size. After CT- and MR-tomographic
conﬁrmation of a tumor in the sellar/suprasellar region and an
endocrinological work-up, most patients are transferred to the
neurosurgeon for surgical treatment. Preoperative imaging can-
not replace the histological analysis and diagnosis “craniopharyn-
gioma” – however certain typical characteristics make the diag-
nosis likely (Rennert and Doerﬂer, 2007). Goals of surgery can
be: histological conﬁrmation of diagnosis, relief of mass effects,
treatment of hydrocephalus, preservation of hormonal function,
avoidance of complications, and if possible, complete resection
(CR) of the pathology. Especially in older publications, the surgical
strategy generally opted for complete/gross-total tumor resection.
It is indisputable, that aggressive surgical procedures more fre-
quently lead to hypopituitarism or – even worse – hypothalamic
damage and obesity (Lustig et al., 2003). Therefore, a different
approach is to preserve endocrine function and avoid pituitary
stalk and hypothalamic manipulation as much as possible, accept-
ing an incomplete resection (Schubert et al., 2009). These patients
are usually candidates for radiotherapy (Becker et al., 1999; Smee
et al., 2011).
ANATOMICAL CONSIDERATIONS AND SUGGESTION OF A
MRI CLASSIFICATION
As already mentioned, craniopharyngiomas are midline lesions
of the middle cranial fossa, considered to arise from remnants
of the Rathke’s pouch. About 30% of the tumors have an intrasel-
lar/infradiaphragmatic origin,whereas the rest either has its major
extension above the sella turcica underneath the optic chiasm, or
a mostly supra-/retrochiasmatic extension usually into the third
ventricle, affecting hypothalamic structures and possibly lead-
ing to occlusive hydrocephalus. Depending on its location, the
tumor causes different symptoms, e.g., hydrocephalus in intra-
ventricular tumors, whereas growth arrest, pituitary insufﬁciency
and Diabetes insipidus are more likely the leading symptoms in
infradiaphragmatic and infrachiasmatic tumors. Tumors originat-
ing from the pituitary stalk are frequently leading to chiasmatic
syndrome. All types are connected with headaches. In cases of
intrasellar tumors or intra- and suprasellar tumors, the ﬂoor of
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the sella turcica is usually enlarged. Most surgeons will advice
transsphenoidal surgery for patients suffering from these lesions
(Abe and Ludecke, 1997).
In supradiaphragmatic–infrachiasmatic lesions, the regionmay
be reached by a transcranial as well as a transsphenoidal approach.
Whereas the access morbidity is considered less in transsphe-
noidal approaches, the control of neurovascular structures may
be limited. Recently, several reports have been published show-
ing good results by extended transsphenoidal surgery (see below).
In all lesions arising from the pituitary stalk, the attempt of a
complete/gross-total surgical resection frequently leads to partial
or complete hypopituitarism.
Suprachiasmatic lesions are generally considered difﬁcult to
treat, connected with high morbidity, and frequently incom-
pletely resected. As published by Müller (2011) and Müller et al.
(2011), the attempt of surgical removal of tumor tissue beyond
the mammillary bodies endangers hypothalamic structures and
may cause hypothalamic obesity. Taking these considerations into
account, a classiﬁcation according to preoperative MRI is sug-
gested, since this may inﬂuence the surgical strategy (Figure 1).
Type 1 craniopharyngiomas are located below the diaphragma sel-
lae, whereas Type 2 tumors are supradiaphragmatic and infrachi-
asmatic. Type 3 craniopharyngiomas are located above the chiasm
(and usually retrochiasmatic, extending into the third ventricle).
The latter Type should be subdivided into Type A and B with
respect to the mammillary bodies, since Type B can be connected
to severe hypothalamic damage, when approached by aggressive
surgery (Müller et al., 2011). Different transcranial approaches
to reach the area can be considered, as discussed later. Only few
Type 3 craniopharyngiomas (mostly cystic) are good candidates
for transsphenoidal surgery.
SPECIAL CONSIDERATIONS IN CHILDHOOD
General precautions have to be taken in children aged 10 or
younger, since the “normal” intraoperative blood loss may cause
life-threatening hypovolemic hypotension. Therefore, an experi-
enced anesthesiology team is mandatory, as well as a meticulous
surgical hemostasis. The use of the Mayﬁeld pin ﬁxation has to
be carefully performed especially in children, since impression
fractures with consecutive epidural hematomas are known and
published complications (Yan, 2007).
As for the development of the skull base, transsphenoidal
surgery is possible in infants from aged 3 years and older,
since the pneumatization of the sphenoid sinus should have
started (Figure 2; Flitsch et al., 2000). For maximum safety in
these patients, the use of a microdoppler, ﬂuoroscopy, or/and
neuronavigation is recommended to avoid vascular complications.
TRANSCRANIAL PROCEDURES
The treatment of Type 2 and Type 3 craniopharyngiomas can
be performed via transcranial approaches. Craniopharyngiomas
arising from the pituitary stalk and those lesions extending into
the infundibulum can be reached by a classical pterional or sub-
frontal route (Liu et al., 2010). Limitations are that the optic
nerves/optic chiasm usually lay in front of the tumor and therefore
the surgical window is limited (Figure 3). Also, the identiﬁca-
tion of the pituitary stalk can be difﬁcult and therefore is at high
FIGURE 1 | Sagittal MRI of the midline. Suggestion of a classiﬁcation
system of craniopharyngiomas by preoperative MRI criteria. The intra- and
suprasellar region can be divided into three sections. Section 1 is limited by
the diaphragm sella, section 2 is below the optic chiasm and the
mammillary bodies, section 3 is above the chiasm and mammillary bodies,
subdivided into an area anterior and posterior of the mammillary bodies. In
this particular patient, a transsphenoidal surgery of a Type 1
craniopharyngioma was performed previously, as can be seen by ﬂuid
within the sphenoid sinus. Section 1 is usually reached by the
transsphenoidal route, whereas section 3a and 3b is mostly reserved for
transcranial procedures. Depending on the tumor extension, section 2 can
be reached by transcranial as well as transsphenoidal procedures.
risk. Tumors extending into the third ventricle can be reached
by opening of the lamina terminalis behind the optic chiasm
(Maira et al., 2000). Tumor cysts can be opened, however, for
removal of the cyst wall or solid parts, the adjacent hypothal-
amic tissue is more or less manipulated. Another approach for
large tumors within the ventricle is the transventricular route
through a lateral ventricle and the foramen of Monroi (Kono-
valov, 1993). This approach may be considered in obstructive
hydrocephalus.Retrosigmoid approaches for uncommonposterior
fossa tumor extensions are rarely necessary. In all cases of incom-
plete tumor removal during transcranial procedures, catheters
connected with, e.g., a Rickham reservoir can be inserted into
remaining cysts for later aspiration or instillation of sclerosing
substances.
TRANSSPHENOIDAL PROCEDURES
Microscopic transsphenoidal surgery remains the standard
approach to the pituitary region (Fahlbusch and Hofmann, 2008).
Endoscopically assisted techniques have been developed over the
last two decades and enrich the surgical options (Fernandez-
Miranda et al., 2011). Except for very small children with lack of
at least partial sphenoid sinus pneumatization (up to age 3), this
approach is suitable for patientswith infradiaphragmatic lesions as
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FIGURE 2 | Sagittal MRI of a child with an intra- and suprasellar
craniopharyngioma reaching the optic nerves (Type 1). Special attention
has to be given to the partial pneumatization of the sphenoid sinus, since
the thick bone has to be drilled during the access to the sella.This can cause
problems in orientation for the surgeon and endanger the carotid arteries,
which may be solved by the use of a microdoppler and/or neuronavigation.
well as supradiaphragmatic (cystic) Type 2 craniopharyngiomas.
Reports of transsphenoidal resections of tumors within the third
ventricle exist (Gardner et al., 2008;Kitano andTaneda,2009;Cop-
pens and Couldwell, 2010). Especially in childhood, the incom-
plete pneumatization of the sphenoid sinus may require extensive
drilling to access the target (Figure 2). As mentioned, techni-
cal help of ﬂuoroscopy, microdoppler, and neuronavigation are
mandatory (Figure 4). It is of importance to mention, that in
Type 1 lesions the pituitary is anterior of the tumor and has to be
incised and moved laterally to access the tumor. For Type 2 lesions
without extension into the sella, a supradiaphragmatic access is
chosen, leading to an intraoperative CSF leak in all cases, which
may be difﬁcult to close.With the use of extended transsphenoidal
approaches, transcranial approaches of Type 2 and also Type 3
lesions may be more and more replaced.
ENDOSCOPIC PROCEDURES
Endoscopic procedures are usually considered in occlusive hydro-
cephalus caused by tumor cysts of the foramen of Monroi.
The small size of instruments insertable through the work-
ing canals of the endoscope allows only biopsies of the tumor
and prevents larger resections. The standard access is a para-
median frontal burr hole in front of the coronal suture. After
transcortical puncture of the lateral ventricle, the endoscope can
be moved inside the inner CSF space through the foramen of
Monroi within some limits. Besides cyst punctures and biopsies
(Oppido et al., 2011), catheters can be placed under optic control
(Figure 5).
FIGURE 3 | (A,B) Pre- and postoperative MRI of a subtotal resection of a
craniopharyngioma extending into the third ventricle up to the mammillary
bodies in a 4-year-old child. The postoperative MRI shows remaining
intrasellar cystic tumor. Because of missing pneumatization of the sphenoid
sinus a transcranial, pterional approach was chosen.The pituitary stalk could
be preserved in this case. The patient is under close follow-up, in case of
tumor growth prior to pneumatization of the sphenoid sinus, radiotherapy
will be considered. (C)The intraoperative photo shows the optic nerves up
to the chiasm as well as the spread pituitary stalk (arrow) within the cystic
tumor (see parallel running small vessels of the pituitary stalk).
INTRACYSTIC THERAPIES
Stereotactic placement of catheters into craniopharyngioma cysts
with consecutive injection of either radioactive or chemothera-
peutic agents has been performed (Steinbok and Hukin, 2010;
Barriger et al., 2011). More recently, the use of interferon-alpha as
a therapeutic agent was reported (Cavalheiro et al., 2010). These
procedures are limited to mostly cystic lesions, which are difﬁcult
to reach by others procedures. Prior to injection of the chosen
agent it has to be conﬁrmed, that no leakage into the subarach-
noid space is possible. Severe complications have been reported
(Linnert and Gehl, 2009).
STRATEGIES
Complete resection of the tumor may be considered the most
appealing strategy, if feasible. This strategy includes resection of
the outer tumor capsule adjacent to healthy tissue and may sac-
riﬁce functional tissue, leading to endocrine dysfunction as well
as hypothalamic damage. In cases of preoperative panhypopitu-
itarism, less precautions have to be taken by the surgeon and an
aggressive approach seems justiﬁed, as long as the hypothalamus
is not involved. However, from our own experience as well as from
the literature, a true CR is only achieved in a limited number
of patients. Also, the criteria of “CR” vary, since some authors
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FIGURE 4 | (A) Preoperative contrast enhanced MRI showing an
infradiaphragmatic tumor rest after a previous transcranial surgery of a large
craniopharyngioma. (B) Intraoperative ﬂuoroscopy showing the surgical
approach prior to opening of the sellar ﬂoor. Notice the catheter connected
to a Rickham reservoir reaching the suprasellar region, which was
implanted during the previous procedure. (C) Intraoperative microscopic
view showing the catheter tip from the sella using a special mirror
technique (Lüdecke technique). (D) Early postoperative MRI showing the
extent of tumor resection. Up to today, no recurrence is reported.
consider the intraoperative surgical assessment, other papers a
postoperative imaging study, or a combination of both. In gen-
eral, Type 1 and Type 2 lesions may allow a CR without severe
endocrine dysfunction, whereas in Type 3 lesions this strategy is
usually combined with a high morbidity.
Gross-total resection (GTR) comprises near CR (>95%) of the
lesion, leaving, e.g., calciﬁed remnants to the pituitary stalk or
minimal tumor rests within the hypothalamic tissue. This result
is more frequently reported than CR, depending on the location
of the craniopharyngioma. Tumor control rates seem acceptable,
although combined with a high rate of endocrine morbidity. In
general, radiotherapy will only be considered, after a recurrence of
disease is visible in imaging studies.However, this topic is currently
under investigation. The evaluation of resection extend and there-
fore the difference between GTR and CR should rely on imaging
quality and the surgeon’s intraoperative assessment but remains
biased to some degree.
Subtotal resection (STR), leaving considerable tumor rests
in situ, is a common result of craniopharyngioma surgery. For
these patients, radiotherapy is considered after surgery. It is an
ongoing discussion,whether radiotherapy should be administered
immediately after surgery or only after proven regrowth of the
residual disease. Tumor control rates of STR and radiotherapy are
reported similar to GTR, however, morbidity rates seem lower.
A Biopsy (BY) is usually performed in cases of endoscopic
cyst punctures for hydrocephalus to conﬁrm the diagnosis or by
FIGURE 5 | (A,B) Preoperative solid and cystic lesion with large cyst within
the third ventricle, causing headaches. T2 weighed images. (C,D)
Postoperative MRI after endoscopic drainage of the cyst and insertion of a
catheter into the cyst, connected with a frontal Rickham reservoir.
Unfortunately, the infrachiasmatic cysts enlarged in size during follow-up
prior to radiotherapy, requiring additional surgery (not shown).
stereotactic procedures, e.g., during catheter implantation prior to
intracystic therapies.
DISCUSSION
Craniopharyngiomas are classiﬁed as WHO Grade 1 tumors. The
10 year survival rate is found to be over 90% (Mortini et al.,
2011; Müller, 2011), however, morbidity is high and recurrences
are common. The surgical expertise as well as the size of the
tumor/site of origin seems to be the most reliable factors pre-
dicting outcome in patients with craniopharyngiomas (Reschke
et al., 2006; Spoudeas et al., 2006; Zada and Cappabianca, 2010;
Müller et al., 2011; Qi et al., 2011). Whereas the tumor size is
an unchangeable preoperative factor, the surgical strategy can be
varied in patients. Early publications already concluded, that no
forceful attempt should be made to achieve CR to avoid resulting
morbidity (Mori et al., 1980). Perioperative fatal complications
are reported in up to 3% of craniopharyngioma surgery in recent
publications (Yamada et al., 2010; Mortini et al., 2011). The “tra-
ditional” surgical strategy of choice is to aim for a complete/GTR
of the lesion. Some surgeons report complete surgical removal
in up to 70%, however, recurrence rates of 25% are reported
by the same group (Mortini et al., 2011), leaving some doubt
of the extent of resection. Therefore, the deﬁnition of complete
surgical removal has to be strict to avoid misleading expectations
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for follow-up. Nowadays, the intraoperative evaluation of resec-
tion extend should be conﬁrmed by postoperative MR and CT
imaging.
In cases of existingpreoperative panhypopituitarism,an aggres-
sive surgical strategy seems justiﬁed, since accompanied surgical
damage is minimal. Exceptions are hypothalamic involvement;
hypothalamic obesity is a feared complication especially in chil-
dren. Karavitaki et al. (2005) found after a 10-year follow-up
phase up to 40% of patients suffering from obesity. As known
from histological specimen resected during surgery, the tumors
show ﬁnger-like invasion into brain tissue (Burghaus et al., 2010).
The surgical attempt to resect these parts will damage the adja-
cent brain tissue. Müller et al. (2011) found, that the risk of
hypothalamic damage increased, when tumors extend beyond
the mammillary bodies. Van Gompel et al. (2010) reported that
hypothalamic signal changes in T2 weighed MR images as well as
irregular contrast enhancement was found to correlate with and
predict hypothalamic involvement. In another recent publication,
Steno et al. (2011) found a highermorbidity after surgery for intra-
ventricular tumors, when comparing suprasellar extraventricular
tumor extension with intraventricular tumor extension.
There has been debate, whether a GTR is more favorable
regarding outcome compared with STR. In terms of recurrence,
Karavitaki et al. (2005) concluded, that gross-total removal pro-
vides favorable results. On the contrary, Schubert et al. (2009)
found a more favorable outcome in patients with less invasive
procedures compared to more radical approaches. Other authors
found comparable rates of recurrence betweenGTRand STR com-
bined with radiotherapy (Becker et al., 1999; Sughrue et al., 2011).
Sughrue et al. performed a statistical analysis including 274 stud-
ies regarding craniopharyngioma-treatment in 2011 concluding
that GTR results in higher rates of postoperative endocrinopathy
and panhypopituitarism which might reach up to threefold com-
pared to STR and radiotherapy (Sughrue et al., 2011). Recurrence
rates of up to 36% after surgical treatment alone were reported by
Winkﬁeld et al. (2011) compared to recurrence rates of 5% when
limited surgery was combined with postoperative radiotherapy
(seven times higher risk for recurrence). As expected, the morbid-
ity risk increases in these patientswithmore aggressive approaches.
Sughrue et al. (2011) found that patients receiving GTR had
over 2.5 times the rate of developing at least one endocrinopa-
thy compared to patients receiving STR or STR plus radiotherapy.
Abe and Ludecke (1997) concluded that the concept of subtotal
removal with preservation of pituitary functions seemed justiﬁed,
especially in childhood.
Regarding the surgical access strategy, it is generally accepted
that the transsphenoidal approach is the ﬁrst choice in infradi-
aphragmatic craniopharyngiomas with sellar enlargement (Abe
and Ludecke, 1997; Yamada et al., 2010). Over the last years,
several reports of extended approaches to suprasellar cranio-
pharyngiomas have been published (Gardner et al., 2008; Jane
et al., 2010; Yamada et al., 2010). These extended transsphenoidal
approaches for supradiaphragmatic tumors are connected with a
different incidence of endocrinopathies and neurological compli-
cations when compared to infradiaphragmatic lesions, especially
when complete orGTR is attempted (Jane et al., 2010). CSF ﬁstulas
are another complication, which needs meticulous techniques for
prevention. It seems necessary to mention, that success as well as
complications are connected with the experience of the surgeon.
In comparison to transcranial procedures, potential advantages
include the avoidance of craniotomy and brain retraction and
reduced neurovascular manipulation (Dehdashti et al., 2009).
Whether the transsphenoidal approachwillmore andmore replace
transcranial techniques, has to be awaited.
CONCLUSION
The treatment of childhood craniopharyngioma requires an inter-
disciplinary approach. In many cases, surgical options alone pro-
vide immediate relief of compression symptoms. Restitution of
preoperative pituitary insufﬁciencies is not common. CR cannot
be achieved in many cases and without widespread consequences
for the patients’ quality of life. The choice of the “right” surgi-
cal approach, especially for Type 2 and Type 3 tumors, can be
difﬁcult and controversial and should – from the author’s point
of view – be in the hands of highly experienced neurosurgi-
cal/neuropediatric centers, offering all surgical techniques. Every
patient should receive an individually tailored treatment. Recur-
rences are frequent and require a close and continuous follow-up
of the children. Adjuvant radiotherapy should be considered after
incomplete surgical resection. The best timing for postoperative
radiotherapy remains to be examined.
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